Single-frequency, pulsed Yb3+-doped multicomponent phosphate power fiber amplifier

High-power, single-frequency, pulsed fiber amplifiers are required in light detection and ranging, coherent laser detection, and remote sensing applications to reach long range within a short acquisition time. However, the power-scaling of these amplifiers is limited by nonlinearities generated in the optical fibers, in particular by stimulated Brillouin scattering (SBS). In this regard, the use of multicomponent phosphate glasses maximizes the energy extraction and minimizes nonlinearities. Here, we present the development of a single-stage, hybrid, pulsed fiber amplifier using a custom-made multicomponent Yb-doped phosphate fiber. The performance of the phosphate fiber was compared to a commercial Yb-doped silica fiber. While the latter showed SBS limitation at nearly 6.5 kW for 40 cm length, the maximum achieved output peak power for the multicomponent Yb-doped phosphate fiber was 11.7 kW for 9 ns pulses using only 20 cm with no sign of SBS

Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study

Background Data from population-based cancer registries are often used to compare cancer survival between countries or regions. The ICBP SURVMARK-2 study is an international partnership aiming to quantify and explore the reasons behind survival differences across high-income countries. However, the magnitude and relevance of differences in cancer survival between countries have been questioned, as it is argued that observed survival variations may be explained, at least in part, by differences in cancer registration practice, completeness and the availability and quality of the respective data sources. Methods As part of the ICBP SURVMARK-2 study, we used a simulation approach to better understand how differences in completeness, the characteristics of those missed and inclusion of cases found from death certificates can impact on cancer survival estimates. Results Bias in 1- and 5-year net survival estimates for 216 simulated scenarios is presented. Out of the investigated factors, the proportion of cases not registered through sources other than death certificates, had the largest impact on survival estimates. Conclusion Our results show that the differences in registration practice between participating countries could in our most extreme scenarios explain only a part of the largest observed differences in cancer survival